Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate
暂无分享,去创建一个
Harvey J Clewell | Jerry Campbell | P Robinan Gentry | Rebecca Clewell | Cynthia Van Landingham | Annette M Shipp | Jerry L. Campbell | H. Clewell | R. Clewell | P. Gentry | A. Shipp | C. V. Van Landingham | J. Campbell
[1] Bernhard Liebl,et al. Occurrence and daily variation of phthalate metabolites in the urine of an adult population. , 2007, International journal of hygiene and environmental health.
[2] Yi Wang,et al. Public Health Goal for Di ( 2-Ethylhexyl ) Phthalate ( DEHP ) in Drinking Water , 1998 .
[3] G. Wishart,et al. Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme's activity towards twelve substrates. , 1978, The Biochemical journal.
[4] J. Valentin. Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.
[5] R D Short,et al. Metabolic and Peroxisome Proliferation Studies With Di(2-Ethylhexyl)Phthalate in Rats and Monkeys , 1987, Toxicology and industrial health.
[6] D. Longnecker,et al. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. , 1997, Toxicology and applied pharmacology.
[7] Margaret S. Wu,et al. Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice , 2000 .
[8] Per Sjöberg,et al. Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats , 1985, Archives of Toxicology.
[9] S. Meachem,et al. Spermatogonia: stem cells with a great perspective. , 2001, Reproduction.
[10] Fritz Haber,et al. Zur Geschichte des Gaskrieges , 1924 .
[11] J W Bridges,et al. Effects of phthalic acid esters on the liver and thyroid. , 1986, Environmental health perspectives.
[12] D J Paustenbach,et al. Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model. , 1987, American Industrial Hygiene Association journal.
[13] R. M. David,et al. Chronic toxicity of di(2-ethylhexyl)phthalate in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[14] R. Sharpe,et al. Evidence that androgens and oestrogens, as well as follicle-stimulating hormone, can alter Sertoli cell number in the neonatal rat. , 2005, The Journal of endocrinology.
[15] G. Lucier,et al. Steroid and non-steroid UDP glucuronyltransferase: glucuronidation of synthetic estrogens as steroids. , 1977, Journal of steroid biochemistry.
[16] Carol Potera. Air Pollution: Floral Scents Going Off the Air? , 2008, Environmental health perspectives.
[17] James E Klaunig,et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.
[18] G P Daston,et al. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. , 1997, Reproductive toxicology.
[19] D. Longnecker,et al. Interface between adaptive and neoplastic growth in the pancreas. , 1987, Gut.
[20] A H Payne,et al. Comparison of androgen synthesis in human fetal testis and adrenal: 3 -hydroxysteroid dehydrogenase-isomerase and 17 -steroid dehydrognase activities. , 1972, Biochimica et biophysica acta.
[21] Harvey J Clewell,et al. Perchlorate and Radioiodide Kinetics Across Life Stages in the Human: Using PBPK Models to Predict Dosimetry and Thyroid Inhibition and Sensitive Subpopulations Based on Developmental Stage , 2007, Journal of toxicology and environmental health. Part A.
[22] Steven K. Gibb. Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.
[23] H J Clewell,et al. Biologically motivated models for chemical risk assessment. , 1989, Health physics.
[24] H J Clewell,et al. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. , 1995, Chemosphere.
[25] R. M. David,et al. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[26] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[27] Hugh A Barton,et al. Computational Pharmacokinetics During Developmental Windows of Susceptibility , 2005, Journal of toxicology and environmental health. Part A.
[28] Cynthia V. Rider,et al. Cumulative Effects of In Utero Administration of Mixtures of “Antiandrogens” on Male Rat Reproductive Development , 2009, Toxicologic pathology.
[29] R. Cattley,et al. Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis , 2004, Toxicologic pathology.
[30] Holger M Koch,et al. Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine. , 2003, Environmental research.
[31] U. Epa. Guidelines for carcinogen risk assessment , 1986 .
[32] R. Bronaugh,et al. Percutaneous absorption and metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl) phthalate: comparison of in vitro and in vivo results in the hairless guinea pig. , 1992, Toxicology and applied pharmacology.
[33] P. J. Thomford. 26-week capsule toxicity study with ammonium perfluorooctanoate (APFO) in cynomolgus monkeys , 2001 .
[34] T. Lovekamp-Swan,et al. Mechanisms of phthalate ester toxicity in the female reproductive system. , 2002, Environmental health perspectives.
[35] J. Cook,et al. Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism. , 1997, Toxicology and applied pharmacology.
[36] Robert L. Dedrick,et al. Animal scale-up , 1973, Journal of Pharmacokinetics and Biopharmaceutics.
[37] D. Coffin,et al. Di-n-butyl-and Di-2-ethylhexyl phthalate in human adipose tissue , 1974, Bulletin of environmental contamination and toxicology.
[38] M. Bosland,et al. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. , 1996, Progress in clinical and biological research.
[39] I R Rowland,et al. Hydrolysis of phthalate esters by the gastro-intestinal contents of the rat. , 1977, Food and cosmetics toxicology.
[40] Harvey J Clewell,et al. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. , 2008, Regulatory toxicology and pharmacology : RTP.
[41] Paul M D Foster,et al. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. , 2006, International journal of andrology.
[42] W. Krol,et al. Pharmacokinetics of dibutylphthalate in pregnant rats. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[44] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[45] H J Clewell,et al. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.
[46] R. Clewell,et al. The use of physiologically based models to integrate diverse data sets and reduce uncertainty in the prediction of perchlorate and iodide kinetics across life stages and species , 2001, Toxicology and industrial health.
[47] M E Andersen,et al. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. , 1991, Toxicology and applied pharmacology.
[48] J. Haines,et al. International programme on chemical safety , 1996, The Lancet.
[49] M E Andersen,et al. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. , 1990, Toxicology and applied pharmacology.
[50] Ellen J. O'Flaherty,et al. Interspecies Conversion of Kinetically Equivalent Doses1 , 1989 .
[51] L. Gray,et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[52] D. Richardson,et al. The utilization of protein and energy during lactation in the rat, with particular regard to the use of fat accumulated in pregnancy , 1982, British Journal of Nutrition.
[53] James E Klaunig,et al. The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.
[54] J Knopp,et al. Iodine, solid diet, water and milk intake by lactating rats and their offsprings. , 1966, Physiologia Bohemoslovaca.
[55] J P Fabry,et al. In vivo and in vitro percutaneous absorption of [(14)C]di-N-butylphthalate in rat. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[56] Maria Gazouli,et al. Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor α. , 2002, Endocrinology.
[57] P O Droz,et al. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. , 1996, Toxicology and applied pharmacology.
[58] Yun-jung Kim,et al. Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[59] B Staels,et al. Fibrates Suppress Bile Acid Synthesis via Peroxisome Proliferator–Activated Receptor-&agr;–Mediated Downregulation of Cholesterol 7&agr;-Hydroxylase and Sterol 27-Hydroxylase Expression , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[60] Ibrahim Chahoud,et al. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult female offspring rats. , 2006, Toxicology.
[61] D. Lai,et al. Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance , 2004, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[62] Richard A Corley,et al. Evaluation of Physiologically Based Models of Pregnancy and Lactation for Their Application in Children's Health Risk Assessments , 2003, Critical reviews in toxicology.
[63] C. Knight,et al. Mammary cell proliferation in mice during pregnancy and lactation in relation to milk yield. , 1982, Quarterly journal of experimental physiology.
[64] M E Hurtt,et al. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[65] P O Droz,et al. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. , 1996, Toxicology and applied pharmacology.
[66] Harvey J Clewell,et al. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. , 2003, Regulatory toxicology and pharmacology : RTP.
[67] C C Peck,et al. Applications of isotope differentiation for metabolic studies with di-(2-ethylhexyl) phthalate. , 1982, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.
[68] H J Clewell,et al. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.
[69] B. Ji,et al. Human pancreatic acinar cells do not respond to cholecystokinin. , 2002, Pharmacology & toxicology.
[70] A. Martino-Andrade,et al. Reproductive toxicity of phthalate esters. , 2010, Molecular nutrition & food research.
[71] H J Clewell,et al. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. , 1999, Risk analysis : an official publication of the Society for Risk Analysis.
[72] Weihsueh A. Chiu,et al. A Reexamination of the PPAR-α Activation Mode of Action as a Basis for Assessing Human Cancer Risks of Environmental Contaminants , 2009, Environmental health perspectives.
[73] H J Clewell,et al. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. , 1991, Toxicology and applied pharmacology.
[74] P Chowdhury,et al. Exogenous administration of estradiol and cholecystokinin alters exocrine pancreatic function in rats , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.
[75] Jonathan I Levy,et al. Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.
[76] H J Clewell,et al. Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment. , 2000, Environmental health perspectives.
[77] J W Fisher,et al. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. , 2000, Environmental health perspectives.
[78] I. Chahoud,et al. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): effects on androgenic status, developmental landmarks and testicular histology in male offspring rats. , 2006, Toxicology.
[79] R M Sharpe,et al. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. , 1999, Critical reviews in toxicology.
[80] Paul M D Foster,et al. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. , 2002, Reproductive toxicology.
[81] Division on Earth. Risk Assessment in the Federal Government: Managing the Process , 1983 .
[82] C. Knight,et al. Milk yield in rats in relation to activity and size of the mammary secretory cell population , 1984, Journal of Dairy Research.
[83] Hugh A. Barton,et al. Data for Physiologically Based Pharmacokinetic Modeling in Neonatal Animals: Physiological Parameters in Mice and Sprague-Dawley Rats , 2004 .
[84] J. Mandel,et al. PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS , 2000, Drug and chemical toxicology.
[85] Harvey J Clewell,et al. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[86] B. Ji,et al. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. , 2001, Gastroenterology.
[87] M. Ishizuka,et al. AhR and PPARa: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11 , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[88] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[89] M H Wykoff. Weight changes of the developing rat conceptus. , 1971, American journal of veterinary research.
[90] M E Hurtt,et al. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. , 1995, Toxicology and applied pharmacology.
[91] Ibrahim Chahoud,et al. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. , 2004, Toxicology and applied pharmacology.
[92] K Rakusan,et al. Postnatal development of the cardiac output distribution in rat. , 1973, Biology of the neonate.
[93] G. Lucier,et al. Postnatal stimulation of hepatic microsomal enzymes following administration of TCDD to pregnant rats. , 1975, Chemico-biological interactions.
[94] C Owyang,et al. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats. , 1995, Gastroenterology.
[95] F. A. Ubel,et al. Health status of plant workers exposed to fluorochemicals--a preliminary report. , 1980, American Industrial Hygiene Association journal.
[96] Ellen J. O'Flaherty,et al. Physiologically based models for bone-seeking elements , 1991 .
[97] F. Gilliland,et al. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. , 1998, Journal of occupational and environmental medicine.
[98] J M Pellegrino,et al. Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. , 2001, The Journal of pharmacology and experimental therapeutics.
[99] E J O'Flaherty,et al. Physiologically based models for bone-seeking elements. V. Lead absorption and disposition in childhood. , 1995, Toxicology and applied pharmacology.
[100] J. Peters,et al. Involvement of the peroxisome proliferator-activated receptor alpha in regulating long-chain acyl-CoA thioesterases. , 2000, Journal of lipid research.
[101] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[102] R. Maronpot,et al. Triclosan: A critical review of the experimental data and development of margins of safety for consumer products , 2010, Critical reviews in toxicology.
[103] L Earl Gray,et al. Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[104] I. Rusyn,et al. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. , 2000, Antioxidants & redox signaling.
[105] Samuel M Cohen,et al. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[106] Sung Hoon Kim,et al. DI-(2-ETHYLHEXYL) PHTHALATE-INDUCED CELL PROLIFERATION IS INVOLVED IN THE INHIBITION OF GAP JUNCTIONAL INTERCELLULAR COMMUNICATION AND BLOCKAGE OF APOPTOSIS IN MOUSE SERTOLI CELLS , 2002, Journal of toxicology and environmental health. Part A.
[107] Timothy R. Gerrity,et al. Principles of route-to-route extrapolation for risk assessment : proceedings of the Workshops on Principles of Route-to-Route Extrapolation for Risk Assessment held March 19-21, 1990, in Hilton Head, South Carolina and July 10-11, 1990, in Durham, North Carolina , 1990 .
[108] D M Sheehan,et al. Prenatal dexamethasone exposure in rats: effects of dose, age at exposure, and drug-induced hypophagia on malformations and fetal organ weights. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[109] P. Albro,et al. Identification of the metabolites of simple phthalate diesters in rat urine. , 1974, Journal of chromatography.
[110] M E Hurtt,et al. The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[111] A. Laslett,et al. A single dose of Di-(2-ethylhexyl) phthalate in neonatal rats alters gonocytes, reduces sertoli cell proliferation, and decreases cyclin D2 expression. , 2000, Toxicology and applied pharmacology.
[112] B H Alexander,et al. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility , 2003, Occupational and environmental medicine.
[113] Yuki Ito,et al. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. , 2007, Journal of occupational health.
[114] P Fenner-Crisp,et al. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.
[115] R B Conolly,et al. Quantitative evaluation of alternative mechanisms of blood disposition of di(n-butyl) phthalate and mono(n-butyl) phthalate in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[116] Benson T Akingbemi,et al. Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[117] M E Andersen,et al. Development of a physiologically based pharmacokinetic model for chloroform. , 1990, Toxicology and applied pharmacology.
[118] M. V. van Gemert,et al. Amniotic fluid water dynamics. , 2007, Placenta.
[119] Maria Gazouli,et al. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. , 2002, Endocrinology.
[120] R B Conolly,et al. Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in rats. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[121] T H Shepard,et al. Volume and glucose concentration of rat amniotic fluid: effects on embryo nutrition and axis rotation. , 1994, Teratology.
[122] J Christopher Corton,et al. Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract? , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[123] H J Clewell,et al. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. , 2000, Environmental health perspectives.
[124] Jennifer Seed,et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.
[125] C Kemmer,et al. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. , 1983, Atherosclerosis.
[126] Cigdem Tanrikut,et al. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations. , 2007, Reproductive toxicology.
[127] Rebecca A Clewell,et al. Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. , 2002, Environmental health perspectives.
[128] M E Hurtt,et al. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. , 1992, Toxicology and applied pharmacology.
[129] Ivan Rusyn,et al. Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver , 2006, Critical reviews in toxicology.
[130] Melvin E Andersen,et al. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: evaluation with a PBPK model. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[131] M. Andersen,et al. Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.
[132] M. Rao,et al. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator. , 1995, Cancer letters.
[133] R J Kavlock,et al. Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose. , 1995, Regulatory toxicology and pharmacology : RTP.
[134] R. Kruse,et al. Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure , 2005, Environmental health perspectives.
[135] F J Gonzalez,et al. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. , 2000, Molecular pharmacology.
[136] Ibrahim Chahoud,et al. A dose response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult male offspring rats. , 2006, Toxicology.
[137] D C Villeneuve,et al. Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[138] Holger M. Koch,et al. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP , 2005, Archives of Toxicology.
[139] R. T. Youker,et al. Modulation of Rat Leydig Cell Steroidogenic Function by Di(2-Ethylhexyl)Phthalate1 , 2001, Biology of reproduction.
[140] J M Ward,et al. Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of Di(2-ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptorα-Null Mice , 1998, Toxicologic pathology.
[141] F. Turek,et al. Development of Leydig cell tumors and onset of changes in the reproductive and endocrine systems of aging F344 rats. , 1979, Journal of the National Cancer Institute.
[142] Gerhard Andreas Wiesmüller,et al. Internal phthalate exposure over the last two decades--a retrospective human biomonitoring study. , 2007, International journal of hygiene and environmental health.
[143] Harvey J Clewell,et al. Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for Chloroform , 2006, Journal of toxicology and environmental health. Part A.
[144] R. M. David,et al. Proposed Mode of Action for In Utero Effects of Some Phthalate Esters on the Developing Male Reproductive Tract , 2006, Toxicologic pathology.
[145] Gunnar Johanson,et al. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation , 2005, Archives of Toxicology.
[146] R A Corley,et al. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. , 1994, Toxicology and applied pharmacology.
[147] B. Lake,et al. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. , 1999, Regulatory toxicology and pharmacology : RTP.
[148] Rebecca A Clewell,et al. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[149] D. Shen,et al. Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in rats. , 1985, Toxicology and applied pharmacology.
[150] R. Roberts,et al. The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. , 1999, Carcinogenesis.
[151] Anne Marie Vinggaard,et al. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. , 2006, Toxicology.
[152] Katherine Shea,et al. NTP-CERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-ethylhexyl) phthalate. , 2006, Reproductive toxicology.
[153] R. Caprioli,et al. Phthalate esters in normal and pathological human kidneys , 1979, Bulletin of environmental contamination and toxicology.
[154] F. Gilliland,et al. Mortality among employees of a perfluorooctanoic acid production plant. , 1993, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[155] Stuart C Sealfon,et al. These authors contributed equally to this manuscript. , 2007 .
[156] P. Miller,et al. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. , 1986, The American journal of physiology.
[157] R. Sharpe,et al. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. , 2003, Human reproduction.
[158] Dana B Barr,et al. Urinary and amniotic fluid levels of phthalate monoesters in rats after the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl phthalate. , 2006, Toxicology.
[159] H A el-Masri,et al. Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment. , 1995, Toxicology.
[160] Holger M. Koch,et al. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP , 2004, Archives of Toxicology.
[161] C. Elcombe,et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[162] P. Albro,et al. Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice. , 1986, Environmental health perspectives.
[163] D. Parke,et al. Effects of pregnancy on the metabolism of drugs in the rat and rabbit. , 1973, Biochemical pharmacology.
[164] J L Linzell,et al. The time course of cardiovascular changes in lactation in the rat , 1973, The Journal of physiology.
[165] Kim Boekelheide,et al. Exposure In Utero to Di(n-Butyl) Phthalate Alters the Vimentin Cytoskeleton of Fetal Rat Sertoli Cells and Disrupts Sertoli Cell-Gonocyte Contact1 , 2005, Biology of reproduction.
[166] S Kettle,et al. Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.
[167] F. Belpaire,et al. Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat , 1985, Archives of Toxicology.
[168] Reiko Kishi,et al. Exposure of prepubertal female rats to inhaled di(2-ethylhexyl)phthalate affects the onset of puberty and postpubertal reproductive functions. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[169] T Yamaha,et al. Biochemical studies on phthalic esters. III. Metabolism of dibutyl phthalate (DBP) in animals. , 1978, Toxicology.
[170] L. A. Dostal,et al. Transfer of di(2-ethylhexyl) phthalate through rat milk and effects on milk composition and the mammary gland. , 1987, Toxicology and applied pharmacology.
[171] Takahashi Terue,et al. Biochemical studies on phthalic esters—II: Effects of phthalic esters on mitochondrial respiration of rat liver , 1977 .
[172] Marika Berglund,et al. Phthalate Diesters and Their Metabolites in Human Breast Milk, Blood or Serum, and Urine as Biomarkers of Exposure in Vulnerable Populations , 2007, Environmental health perspectives.
[173] C. Herath,et al. Elevated levels of inhibin-A and immunoreactive inhibin in aged male Wistar rats with testicular Leydig cell tumor. , 2001, Journal of andrology.
[174] David Y. Lai,et al. PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .
[175] Raymond Liu,et al. The Direct Effect of Hepatic Peroxisome Proliferators on Rat Leydig Cell Function in Vitro1 , 1996 .
[176] L Earl Gray,et al. Mechanisms of action of phthalate esters, individually and in combination, to induce abnormal reproductive development in male laboratory rats. , 2008, Environmental research.
[177] Tammie R. Covington,et al. Evaluation of the Potential Impact of Age- and Gender-Specific Lung Morphology and Ventilation Rate on the Dosimetry of Vapors , 2003, Inhalation toxicology.
[178] Reiko Kishi,et al. The Effects of Subacute Inhalation of Di (2‐ethylhexyl) Phthalate (DEHP) on the Testes of Prepubertal Wistar Rats , 2005, Journal of occupational health.
[179] W. Kluwe,et al. Overview of phthalate ester pharmacokinetics in mammalian species. , 1982, Environmental health perspectives.
[180] Ibrahim Chahoud,et al. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): non-monotonic dose-response and low dose effects on rat brain aromatase activity. , 2006, Toxicology.
[181] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.
[182] Yuki Ito,et al. Di(2‐ethylhexyl)phthalate Induces Hepatic Tumorigenesis through a Peroxisome Proliferator‐activated Receptor α‐independent Pathway , 2007 .
[183] H. Akaike. A new look at the statistical model identification , 1974 .
[184] E Mylchreest,et al. Effects of phthalate esters on the developing reproductive tract of male rats , 2001, Human reproduction update.
[185] E J O'Flaherty,et al. A physiologically based kinetic model of rat and mouse gestation: disposition of a weak acid. , 1992, Toxicology and applied pharmacology.
[186] Ian Cousins,et al. Development and application of a generalized physiologically based pharmacokinetic model for multiple environmental contaminants , 2003, Environmental toxicology and chemistry.
[187] P. Foster,et al. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. , 1999, Toxicology and applied pharmacology.
[188] M. Berger,et al. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. , 2005, Toxicology.
[189] P Grasso,et al. Hepatic peroxisome proliferation in rodents and its significance for humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[190] Harvey J Clewell,et al. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling , 2007, Journal of Exposure Science and Environmental Epidemiology.
[191] S Naessany,et al. Onset of a feedback inhibition by testosterone in male rat fetuses. , 1982, Biology of the neonate.
[192] R. M. David,et al. Chronic toxicity of di(2-ethylhexyl)phthalate in mice. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[193] Ibrahim Chahoud,et al. A dose-response study following in utero and lactational exposure to di(2-ethylhexyl)phthalate: effects on female rat reproductive development. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[194] R. Roberts,et al. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review). , 1998, Oncology reports.